Exchange: NSE Sector: Healthcare Industry: Biotechnology
2.53% INR153.80
America/New_York / 8 mai 2024 @ 06:00
FUNDAMENTALS | |
---|---|
MarketCap: | 203 469 mill |
EPS: | -0.250 |
P/E: | -615.20 |
Earnings Date: | May 10, 2024 |
SharesOutstanding: | 1 322.95 mill |
Avg Daily Volume: | 4.70 mill |
RATING 2024-05-08 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Strong Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | ||||
Debt | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -615.20 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -615.20 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
INR-126.63 (-182.33%) INR-280.43 |
Date: 2024-05-08 |
Expected Trading Range (DAY) |
---|
INR 148.58 - 159.02 ( +/- 3.40%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | INR153.80 (2.53% ) |
Volume | 4.79 mill |
Avg. Vol. | 4.70 mill |
% of Avg. Vol | 101.75 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.